Perrigo Company plc Derivative Notional Amount
Perrigo Company plc (PRGO) had Derivative Notional Amount of $441.00 million as of 2014-09-27, per its 8-K filed 2014-11-20.
Discontinued › Notes › Derivative Instruments and Hedging Activities
invest:DerivativeNotionalAmount · last filed 2014-11-20
- 2014-09-27: Derivative, Notional Amount $441.00M.
- 2014-06-28: Derivative, Notional Amount $468.50M.
- 2014-03-29: Derivative, Notional Amount $492.50M.
- 2013-12-28: Derivative, Notional Amount $467.10M.
| Period end | Derivative, Notional Amount |
|---|---|
| 2014-09-27 | $441.00M 8-K · filed 2014-11-20 |
| 2014-06-28 | $468.50M 8-K · filed 2014-11-20 |
| 2014-03-29 | $492.50M 10-Q · filed 2014-05-07 |
| 2013-12-28 | $467.10M 10-Q · filed 2014-02-06 |
| 2013-06-29 | $494.90M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |